OBGYN Presents RSSP: "DHES0815A, a Novel Antibody-drug Conjugate Targeting HER2/neu, is Highly Active Against Uterine Serous Carcinomas In Vitro and In Vivo"
Zoom link to be provided at a later time.
RSSP presentation by Joan R. Tymon-Rosario, MD on "DHES0815A, a Novel Antibody-drug Conjugate Targeting HER2/neu, is Highly Active Against Uterine Serous Carcinomas In Vitro and In Vivo"
Contact
Host
Host Organization
Admission
Free
Tag
Lectures and Seminars